Top Markets
Coin of the day
Gujarat Themis Biosyn Ltd. Gujarat Themis Biosyn Ltd.

Gujarat Themis Biosyn Ltd.

GUJTHEM
Pozycja w akcjach #13260
Gujarat Themis Biosyn Ltd. is an Indian company primarily involved in the... Gujarat Themis Biosyn Ltd. is an Indian company primarily involved in the creation of pharmaceuticals and medicinal chemicals. The firm also supplies bulk drugs via a job work model within India. Its product offerings include important compounds such as Rifamycin-S, an intermediate used in treatments for tuberculosis, Mycobacterium avium complex, leprosy, and Legionnaires' disease. Another key product, Rifamycin-O, addresses ailments like traveler's diarrhea, irritable bowel syndrome, and hepatic encephalopathy. Furthermore, they produce Lovastatin. Established in 1981, the company's operations are based out of Mumbai, India.
Cena akcji
$4.66
Kapitalizacja rynkowa
$507.71M
Zmiana (1 dzień)
2.94%
Zmiana (1 rok)
8.43%
Kraj
IN
Handel Gujarat Themis Biosyn Ltd. (GUJTHEM)

Kategoria

Historia stopy dywidendy dla Gujarat Themis Biosyn Ltd. (GUJTHEM)
Stopa dywidendy (TTM) dla Gujarat Themis Biosyn Ltd. (symbol akcji: GUJTHEM) na dzień 2026 wynosi: 0
Średnia stopa dywidendy z ostatnich 5 lat: 0.00%
Historia stopy dywidendy dla Gujarat Themis Biosyn Ltd. (GUJTHEM) od 2026 do 2026
Stopa dywidendy na koniec każdego roku (TTM)
Rok Stopa dywidendy Zmień
Za mało danych dla podanych dat.
Stopy dywidendy (TTM) dla podobnych firm lub konkurencji